Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
CC transcript
Inv. presentation

Jazz Pharmaceuticals plc (JAZZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2023 4 ORiordan Anne (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.158, valued at $171.5k
08/15/2023 4 O'Keefe Kenneth W (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1585, valued at $171.5k
08/15/2023 4 Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1584, valued at $171.5k
08/15/2023 4 Sohn Catherine A. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1585, valued at $171.5k
08/15/2023 4 Smith Mark Douglas (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1579, valued at $171.5k
08/15/2023 4 RIEDEL NORBERT G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1581, valued at $171.5k
08/15/2023 4 Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
08/15/2023 4 McSharry Heather Ann (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,344 shares @ $138.1586, valued at $185.7k
08/15/2023 4 Henderson Mary Elizabeth (SVP, Technical Operations) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 10,763 shares @ $0
08/15/2023 4 Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1584, valued at $171.5k
08/15/2023 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1585, valued at $171.5k
08/15/2023 4 Cook Jennifer E. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1581, valued at $171.5k
08/15/2023 4 Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Sold 158 shares @ $138.1575, valued at $21.8k
08/14/2023 3 Henderson Mary Elizabeth (SVP, Technical Operations) has filed a Form 3 on Jazz Pharmaceuticals plc
08/09/2023 4 Patil Neena M (EVP & Chief Legal Officer) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Disposed/sold 1,390 shares @ $131.51, valued at $182.8k
06/12/2023 4 Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Exercised 4,500 options to buy @ $81.76, valued at $367.9k
06/09/2023 4 Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Sold 126 shares @ $127.916, valued at $16.1k
06/07/2023 4 Iannone Robert (EVP, Global Head of Research a) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Disposed/sold 1,311 shares @ $129.73, valued at $170.1k
06/07/2023 4 Sablich Kim (EVP, GM of U.S.) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Disposed/sold 2,082 shares @ $129.73, valued at $270.1k
05/19/2023 4 GALA RENEE D (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Sold 6,000 shares @ $131.7457, valued at $790.5k
03/17/2023 4 Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Sold 1,023 shares @ $133.22, valued at $136.3k
03/10/2023 4 Sablich Kim (EVP, GM of U.S., Commercial Ma) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Sold 1,752 shares @ $139.42, valued at $244.3k
Sold 1,261 shares @ $140.19, valued at $176.8k
03/09/2023 4 O'Keefe Kenneth W (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Sold 2,690 shares @ $138.3894, valued at $372.3k
Exercised 4,500 options to buy @ $81.76, valued at $367.9k
03/07/2023 4 Larkin Finbar (SVP, Technical Operations) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 4,373 shares @ $0
Sold 1,706 shares @ $143.919, valued at $245.5k
Sold 2,075 shares @ $140.7619, valued at $292.1k
Exercised 1,706 options to buy @ $58.72, valued at $100.2k
03/07/2023 4 Swisher Daniel N JR (President and COO) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 13,456 shares @ $0
Paid exercise price by delivering 5,426 shares @ $142.78, valued at $774.7k
03/07/2023 4 Iannone Robert (EVP, Global Head of Research a) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 12,447 shares @ $0
Paid exercise price by delivering 2,274 shares @ $142.78, valued at $324.7k
03/07/2023 4 Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 2,523 shares @ $0
Sold 1,148 shares @ $140.7612, valued at $161.6k
03/07/2023 4 GALA RENEE D (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 12,784 shares @ $0
Paid exercise price by delivering 1,557 shares @ $142.78, valued at $222.3k
03/07/2023 4 Patil Neena M (EVP & Chief Legal Officer) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 9,419 shares @ $0
Paid exercise price by delivering 1,923 shares @ $142.78, valued at $274.6k
03/07/2023 4 Pearce Samantha (SVP, Head of Europe & Internat) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,870 shares @ $0
Paid exercise price by delivering 2,020 shares @ $142.78, valued at $288.4k
03/07/2023 4 Sablich Kim (EVP, GM of U.S., Commercial Ma) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 10,429 shares @ $0
Paid exercise price by delivering 1,610 shares @ $142.78, valued at $229.9k
03/07/2023 4 COZADD BRUCE C (Chairman & CEO) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 42,388 shares @ $0
Paid exercise price by delivering 21,882 shares @ $142.78, valued at $3.1M
03/07/2023 4 Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Exercised 4,500 options to buy @ $59.13, valued at $266.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy